News | March 06, 2024
Bayer aims to enhance performance and regain strategic flexibility by 2026
Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis
Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis
Investigational cell therapy bemdaneprocel continues to be well tolerated with no major safety issues in all 12 participants in low and high dose cohorts through 18 months
Connecting new production and consumption areas of chilled food by low-carbon transportation services
The proposed hospital will have a bed capacity of 300 beds and the investment in the project is expected to be around Rs. 500 crore
This agreement paves the way for the introduction of YESAFILI into the Canadian market
With this, the total number of Patents granted to company for its innovative processes and technology stands at 9
Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
The plant will drive pharmaceutical innovation in the Northeastern India
Subscribe To Our Newsletter & Stay Updated
